Patient who has chest pain and new onset atrial fibrillation - Nursing Case Study

Pathophysiology

• Primary mechanism: Atrial fibrillation is often triggered by abnormal electrical impulses in the atria, leading to rapid and irregular heartbeats. This disorganized electrical activity can result in ineffective atrial contractions, reducing cardiac output and potentially causing chest pain due to decreased coronary perfusion.

• Secondary mechanism: The irregular and rapid atrial contractions can lead to blood pooling in the atria, increasing the risk of clot formation. This can compromise blood flow and exacerbate the chest pain by further reducing oxygen supply to the heart muscle.

• Key complication: The combination of reduced cardiac output and potential clot formation may lead to ischemic events, such as myocardial infarction or stroke, highlighting the need for immediate clinical intervention to manage rhythm and anticoagulation.

Patient Profile

Demographics:

65-year-old male, retired firefighter

History:

• Key past medical history: Hypertension, hyperlipidemia

• Current medications: Lisinopril, atorvastatin, aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain and palpitations

• Key symptoms: Chest pain, new onset atrial fibrillation, dizziness, shortness of breath

• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm (irregular), respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

Change in Patient Status:

During a routine reassessment, the nurse notes that the patient's condition has evolved. The patient reports a sudden increase in chest pain, now rating it at 8 out of 10 on the pain scale. His skin appears pale and diaphoretic, and he expresses a feeling of impending doom. The vital signs reveal a further decrease in oxygen saturation to 88% despite supplemental oxygen via nasal cannula. Heart rate remains irregular but has increased to 130 bpm. Blood pressure is now 140/90 mmHg. These changes suggest a potential acute coronary syndrome or worsening heart failure due to the ongoing atrial fibrillation.

In light of these developments, the clinical team decides to obtain an urgent electrocardiogram (ECG) and initiate a continuous cardiac monitoring. The ECG confirms rapid atrial fibrillation with a ventricular response rate of 130 bpm and ST-segment depression in the inferior leads, indicating possible myocardial ischemia. Blood tests reveal elevated troponin levels, further supporting the suspicion of myocardial infarction. The nurse quickly initiates protocol for acute coronary syndrome, reviewing the necessity of further anticoagulation and rate control measures. The patient's new symptoms necessitate careful monitoring and collaborative decision-making regarding potential transfer to a higher level of care for possible percutaneous coronary intervention.

This evolving scenario requires the clinical team to carefully consider the balance between managing the atrial fibrillation and addressing the ischemic changes. They must prioritize interventions that stabilize the patient's hemodynamic status, prevent further myocardial damage, and mitigate the risk of thromboembolic events. The next steps involve reassessing the patient's response to the interventions and preparing for potential complications, such as heart failure exacerbation or arrhythmia-induced hemodynamic instability.

Section 2

As the clinical team initiates treatment for acute coronary syndrome, they prioritize stabilizing the patient's hemodynamic status and managing the rapid atrial fibrillation. The administration of intravenous beta-blockers is considered to control the heart rate, while low molecular weight heparin is started to address the risk of thromboembolism. Despite these interventions, the patient's condition continues to evolve. Over the next hour, the nurse notes that the patient becomes increasingly restless and reports dyspnea. His oxygen saturation drops further to 85% despite increasing supplemental oxygen delivery through a non-rebreather mask. Auscultation of the lungs reveals crackles at the bases, suggesting pulmonary congestion.

Recognizing the signs of potential heart failure exacerbation, the medical team decides to administer a diuretic to relieve pulmonary congestion. However, the patient's blood pressure begins to decline, dropping to 110/70 mmHg, raising concerns about maintaining adequate perfusion. This necessitates a delicate balance in fluid management as the team aims to alleviate the pulmonary edema while ensuring sufficient cardiac output. The nurse closely monitors for signs of worsening perfusion, such as altered mental status or decreased urine output, which could indicate a progression to cardiogenic shock.

The laboratory results return, showing a further rise in troponin levels, confirming the ongoing myocardial injury. The team discusses the urgency of transferring the patient to the cardiac catheterization lab for potential percutaneous coronary intervention. The nurse prepares the patient for transport, ensuring continuous cardiac monitoring and maintaining intravenous access for potential emergency medications. The evolving scenario highlights the complexity of managing concurrent cardiac complications, necessitating prompt, coordinated interventions and careful clinical reasoning to stabilize the patient and prevent further deterioration.

Section 3

As the patient is prepared for transport to the cardiac catheterization lab, the nurse continues to monitor his vital signs closely. Despite the initiation of diuretic therapy aimed at reducing pulmonary congestion, the patient's blood pressure further declines to 98/65 mmHg, increasing concerns about adequate tissue perfusion. The nurse notes that the patient's skin is cool and clammy, and his capillary refill time has slowed to over three seconds, suggesting compromised peripheral circulation. Additionally, the patient exhibits an altered mental state, becoming slightly confused and disoriented, which could be indicative of reduced cerebral perfusion. These findings raise the suspicion of progressing cardiogenic shock, prompting the medical team to evaluate the need for inotropic support to stabilize hemodynamics.

Simultaneously, the patient's laboratory results return with an alarming increase in B-type natriuretic peptide (BNP) levels, further corroborating the diagnosis of acute heart failure. The electrocardiogram continues to show rapid atrial fibrillation, and there is a new finding of ST-segment depression in the anterior leads, suggesting worsening ischemia. The elevated troponin levels, combined with these ECG changes, underscore the urgency of coronary artery intervention. The team discusses the potential challenge of balancing the patient's hemodynamic instability with the need for urgent revascularization.

In response to the patient's deteriorating condition, the medical team decides to initiate a low-dose infusion of dobutamine to enhance cardiac contractility and improve perfusion without significantly increasing myocardial oxygen demand. Concurrently, they prepare for an expedited transfer to the catheterization lab, ensuring that all necessary medications and equipment are ready for immediate use upon arrival. The unfolding scenario necessitates ongoing clinical reasoning to manage the interplay of heart failure, atrial fibrillation, and myocardial ischemia, highlighting the complexity of optimizing care for this patient.

Section 4

As the patient is transferred to the cardiac catheterization lab, the medical team continues to closely monitor his response to the dobutamine infusion. Initially, there is a slight improvement in the patient's blood pressure, which rises to 105/70 mmHg, and his heart rate steadies at around 110 beats per minute. However, the patient's mental status remains altered, with only minimal improvement in his orientation and responsiveness. This persistent confusion suggests that while peripheral perfusion may have improved slightly, cerebral perfusion is still inadequate. The nurse notes that the patient's skin remains cool and clammy, and capillary refill time is still prolonged, further indicating ongoing circulatory compromise.

New diagnostic results provide additional insights into the patient's condition. The repeat electrocardiogram shows persistent rapid atrial fibrillation, but now with more pronounced ST-segment depression, particularly in leads V2 to V4, indicating increased myocardial ischemia. The troponin levels have further escalated, pointing to continued myocardial injury. A follow-up chest X-ray reveals worsening pulmonary congestion, despite the earlier administration of diuretics, raising concerns about the efficacy of current heart failure management strategies.

Recognizing the potential for new complications, the medical team considers additional therapeutic strategies. They deliberate the use of advanced mechanical circulatory support options, such as an intra-aortic balloon pump, to improve coronary artery perfusion and reduce cardiac workload. Meanwhile, the urgency of revascularization remains a priority, and discussions with the interventional cardiologist focus on the timing and approach to angiography and possible percutaneous coronary intervention. This evolving scenario highlights the need for ongoing reassessment and adaptation of the treatment plan, requiring the healthcare team to carefully balance the immediate risks with the potential benefits of various interventions.

Section 5

As the patient is prepared for potential interventions, a sudden change in his status prompts immediate attention. The nurse observes that the patient's respiratory rate has increased to 28 breaths per minute, and his oxygen saturation has dropped to 88% on supplemental oxygen. Auscultation of the lungs reveals new bilateral crackles, more pronounced at the bases, suggesting worsening pulmonary edema. Concurrently, the patient's blood pressure begins to decline again, now measuring 90/60 mmHg, and his heart rate escalates to 130 beats per minute, reflecting a possible deterioration in his hemodynamic stability.

In response to these changes, the healthcare team swiftly reassesses the patient's overall condition. The increased respiratory distress and hypoxemia raise concerns about the potential for acute decompensated heart failure, exacerbated by the ongoing myocardial ischemia. The team considers the possibility of progression to cardiogenic shock, given the declining blood pressure and persistent signs of poor perfusion, including the patient's continued altered mental status and cool extremities.

Recognizing the urgency of the situation, the medical team decides to implement additional supportive measures. The decision is made to initiate an intra-aortic balloon pump (IABP) to enhance coronary perfusion and decrease cardiac workload, while simultaneously preparing the patient for emergent coronary angiography to address the underlying ischemic burden. This approach aims to stabilize the patient's hemodynamics and improve oxygenation, creating a window of opportunity for definitive revascularization. The team remains vigilant for further complications, ready to adapt their management strategy based on the patient's evolving clinical response.